5 edition of European Organization for Research on the Treatment of Cancer Genitourinary Group Monograph (Progess in Clinical & Biological Research) found in the catalog.
August 21, 1985
by John Wiley & Sons Inc
Written in English
|The Physical Object|
|Number of Pages||684|
Equivalence of Three or Four Cycles of Bleomycin, Etoposide, and Cisplatin Chemotherapy and of a 3- or 5-Day Schedule in Good-Prognosis Germ Cell Cancer: A Randomized Study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Cited by: Schröder FH, Whelan, P, Kurth, KH, Sylvester, R, Pauw, M de, and members of the EORTC Genitourinary Group. Antiandrogens as monotherapy for metastatic prostate cancer: a preliminary report on EORTC protocol , in Recent Advances in Prostate Cancer .
Clear-cell renal cell carcinoma (RCC) is the most common kidney cancer. New treatment options of localized RCC recently incorporated include laparoscopic surgery, nephron-sparing Author: Xavier García del Muro, Enrique Gallardo, Iciar García Carbonero, Nuria Laínez, María José Méndez, P. de Reijke TM, Kurth KH, Sylvester RJ, et al. European Organization for the Research and Treatment of Cancer-Genito-Urinary Group. Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer—Genito-Urinary Group.
Title Sources; EORTC Genitourinary Group monograph 2, Mechanisms of progression to hormone-independent growth of breast and prostatic cancer. Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Cited by:
An Order for prayer for use in Sunday schools
A letter to the inhabitants of the city and state of New-York, on the subject of the commerce of the western waters
Yearning for the wind
Miltonic setting, past & present.
Licensing Bill [HL]
Carbohydrate-based vaccines and immunotherapies
Marriage customs among Muslims in India
One hundred years, 1864-1964
Improving outcomes in head and neck cancers
Vital records of Castine, Maine
The land of the north
EORTC Genitourinary Group monograph 2. New York: Liss, (OCoLC) Online version: EORTC Genitourinary Group monograph 2. New York: Liss, (OCoLC) Material Type: Conference publication: Document Type: Book: All Authors / Contributors: Fritz H Schroeder; B A Richards; European Organization for Research on Treatment of Cancer.
Genito-Urinary Tract Cancer Cooperative Group. Author(s): Schröder,F H; Richards,B A(Brian Alfred); European Organization for Research on Treatment of Cancer. Genito-Urinary Tract Cancer Cooperative Group. Title(s): Therapeutic principles in metastatic prostatic cancer: proceedings of a symposium held in Rotterdam, the Netherlands, September 14 / editors, Fritz H.
Schroeder, Brian Richards. Description: xiii, p.: ill. Language: English ISBN:LCCN: MeSH: Urogenital Neoplasms* Publication Type(s): Congresses Notes: European Organization for Research on the Treatment of Cancer Genitourinary Group monograph series ; no.
Includes bibliographies and index. NLM ID: [Book]. European Organization for Research on the Treatment of Cancer Genitourinary Group monograph series ; monograph 2, pt. Includes bibliographies and index. NLM ID: [Book]. During the past 25 years the EORTC has progressively become the largest organization for therapeutic cancer research in Europe.
Inthe NCI in Washington stated that its creation has been "the most important development in therapeutic research on cancer in Europe."Author: Maurice Tubiana. Author(s): Smith,P H(Philip Henry); Pavone-Macaluso,Michele; European Organization for Research on Treatment of Cancer.
Genito-Urinary Tract Cancer Cooperative Group. A PROSPECTIVE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER GENITOURINARY GROUP RANDOMIZED TRIAL COMPARING TRANSURETHRAL RESECTION FOLLOWED BY A SINGLE INTRAVESICAL INSTILLATION OF EPIRUBICIN OR WATER IN SINGLE STAGE Ta, T1 PAPILLARY CARCINOMA OF THE BLADDER WILLEM OOSTERLINCK, KARL HEINZ KURTH, FRITZ SCHRÃ–DER, JOZEF BULTINCK, BERNADETTE HAMMOND, RICHARD SYLVESTER Cited by: Vrouw Hospital, Aalst and European Organization for Research and Treatment of Cancer Data Center, Brussels, Belgium ABSTRACT From to the European Organization for Research and Treatment of Cancerâ€”Genitourinary Group Cited by: Joint Radiotherapy Committee of the European Organization for Research and Treatment of Cancer (EORTC) Genitourinary and Radiotherapy Groups.
J Surg Oncol8. Vapnek J, Author: Richard Krieg, Rex Hoffman. ESMO has Clinical Practice Guidelines on the following Urogenital Cancers: Prostate cancer, Bladder cancer, Renal cell cancer (RCC) Penile cancer and Testicular seminoma and non-seminoma. They include information on incidence, diagnosis, staging and risk assessment, treatment.
Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary.
Author(s): Debruyne,F M J,; Denis,L; Meijden,Ad P M van der; European Organization for Research on Treatment of Cancer.
Genito-Urinary Tract Cancer Cooperative Group.; Katholieke Universiteit Nijmegen. Quality of life as measured by the European Organization of Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) - Core (C) 30 + QLQ - Prostate (PR) OUTLINE: Patients receive hydroxychloroquine orally (PO) twice daily (BID) for 2 weeks, then undergo standard of care stereotactic body radiation therapy.
This manuscript paper has focused on the management of genitourinary symptoms and outlined the possible management options in women with breast cancer.
HT is not recommended in women with a history of breast cancer, but there is a wide range of other management options available that can improve genitourinary Cited by: Part of the Cancer Treatment and Research book series (CTAR, volume 34) Log in to check access.
Buy eBook. USD Search within book. Front Matter. Pages I-XIII. PDF. Isoenzymes in prostate cancer. RISK ASSESSMENT FOR METASTATIC TESTIS CANCER.
and bleomycin, and cisplatin, vinblastine, and bleomycin performed by the European Organization for Research and Treatment of Cancer (EORTC) In Prostate Cancer and Testicular Cancer, EORTC Genitourinary Group Monograph Cited by: Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary al Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary.
The European Organisation for Research and Treatment of Cancer (EORTC) is a unique pan-European non-profit clinical cancer research organisation established in operating as an international association under Belgium law. It develops, conducts, coordinates and stimulates high-quality translational and clinical trial research to improve the survival and quality of life of cancer.
This book, now in an extensively revised second edition, provides an exhaustive review of the state of the art in the management of prostate cancer, from screening to treatment, with.
Get this from a library. Treatment of prostatic cancer: facts and controversies: proceedings of an EORTC Genitourinary Group sponsored meeting held at Sorrento Palace, Sorrento, Italy, on October[F H Schröder; European Organization for Research on Treatment of Cancer.
Genito-Urinary Tract Cancer Cooperative Group.;]. The NCI Dictionary of Cancer Terms features 8, terms related to cancer and medicine. We offer a widget that you can add to your website to let users look up cancer-related terms.
Get NCI’s Dictionary of Cancer. XRCC1 ArgTrp, Palb2 TT (T>G), HMMR VA, TNF aGA polymorphisms as diagnostic and prognostic markers of breast cancer in the Kyrgyz ethnic group .View summary report as HTML or PDF View French version of The NEJM summary (hosted by Centre Léon Bérard).
A Working Group of 29 independent experts from 16 countries, convened by the International Agency for Research on Cancer (IARC) in Novemberreviewed the scientific evidence and assessed the cancer-preventive and adverse effects of various methods of screening for breast cancer.